262 related articles for article (PubMed ID: 9067577)
1. The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins.
Uemura N; Salgia R; Li JL; Pisick E; Sattler M; Griffin JD
Leukemia; 1997 Mar; 11(3):376-85. PubMed ID: 9067577
[TBL] [Abstract][Full Text] [Related]
2. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
Sattler M; Salgia R; Okuda K; Uemura N; Durstin MA; Pisick E; Xu G; Li JL; Prasad KV; Griffin JD
Oncogene; 1996 Feb; 12(4):839-46. PubMed ID: 8632906
[TBL] [Abstract][Full Text] [Related]
3. p130CAS forms a signaling complex with the adapter protein CRKL in hematopoietic cells transformed by the BCR/ABL oncogene.
Salgia R; Pisick E; Sattler M; Li JL; Uemura N; Wong WK; Burky SA; Hirai H; Chen LB; Griffin JD
J Biol Chem; 1996 Oct; 271(41):25198-203. PubMed ID: 8810278
[TBL] [Abstract][Full Text] [Related]
4. Role of the adapter protein CRKL in signal transduction of normal hematopoietic and BCR/ABL-transformed cells.
Sattler M; Salgia R
Leukemia; 1998 May; 12(5):637-44. PubMed ID: 9593259
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
Jain SK; Langdon WY; Varticovski L
Oncogene; 1997 May; 14(18):2217-28. PubMed ID: 9174058
[TBL] [Abstract][Full Text] [Related]
6. The adapter protein Crkl links Cbl to C3G after integrin ligation and enhances cell migration.
Uemura N; Griffin JD
J Biol Chem; 1999 Dec; 274(53):37525-32. PubMed ID: 10608804
[TBL] [Abstract][Full Text] [Related]
7. CRKL links p210BCR/ABL with paxillin in chronic myelogenous leukemia cells.
Salgia R; Uemura N; Okuda K; Li JL; Pisick E; Sattler M; de Jong R; Druker B; Heisterkamp N; Chen LB
J Biol Chem; 1995 Dec; 270(49):29145-50. PubMed ID: 7493940
[TBL] [Abstract][Full Text] [Related]
8. BCR/ABL-induced leukemogenesis causes phosphorylation of Hef1 and its association with Crkl.
de Jong R; van Wijk A; Haataja L; Heisterkamp N; Groffen J
J Biol Chem; 1997 Dec; 272(51):32649-55. PubMed ID: 9405482
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin and interleukin-3 activate tyrosine phosphorylation of CBL and association with CRK adaptor proteins.
Barber DL; Mason JM; Fukazawa T; Reedquist KA; Druker BJ; Band H; D'Andrea AD
Blood; 1997 May; 89(9):3166-74. PubMed ID: 9129019
[TBL] [Abstract][Full Text] [Related]
10. Interactions of CBL with BCR-ABL and CRKL in BCR-ABL-transformed myeloid cells.
Bhat A; Kolibaba K; Oda T; Ohno-Jones S; Heaney C; Druker BJ
J Biol Chem; 1997 Jun; 272(26):16170-5. PubMed ID: 9195915
[TBL] [Abstract][Full Text] [Related]
11. Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3G.
Posern G; Zheng J; Knudsen BS; Kardinal C; Müller KB; Voss J; Shishido T; Cowburn D; Cheng G; Wang B; Kruh GD; Burrell SK; Jacobson CA; Lenz DM; Zamborelli TJ; Adermann K; Hanafusa H; Feller SM
Oncogene; 1998 Apr; 16(15):1903-12. PubMed ID: 9591773
[TBL] [Abstract][Full Text] [Related]
12. The two major sites of cbl tyrosine phosphorylation in abl-transformed cells select the crkL SH2 domain.
Andoniou CE; Thien CB; Langdon WY
Oncogene; 1996 May; 12(9):1981-9. PubMed ID: 8649859
[TBL] [Abstract][Full Text] [Related]
13. Differential signaling after beta1 integrin ligation is mediated through binding of CRKL to p120(CBL) and p110(HEF1).
Sattler M; Salgia R; Shrikhande G; Verma S; Uemura N; Law SF; Golemis EA; Griffin JD
J Biol Chem; 1997 May; 272(22):14320-6. PubMed ID: 9162067
[TBL] [Abstract][Full Text] [Related]
14. The product of the cbl oncogene forms stable complexes in vivo with endogenous Crk in a tyrosine phosphorylation-dependent manner.
Ribon V; Hubbell S; Herrera R; Saltiel AR
Mol Cell Biol; 1996 Jan; 16(1):45-52. PubMed ID: 8524328
[TBL] [Abstract][Full Text] [Related]
15. Sos, Vav, and C3G participate in B cell receptor-induced signaling pathways and differentially associate with Shc-Grb2, Crk, and Crk-L adaptors.
Smit L; van der Horst G; Borst J
J Biol Chem; 1996 Apr; 271(15):8564-9. PubMed ID: 8621483
[TBL] [Abstract][Full Text] [Related]
16. Identification of CRKL as the constitutively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells.
Nichols GL; Raines MA; Vera JC; Lacomis L; Tempst P; Golde DW
Blood; 1994 Nov; 84(9):2912-8. PubMed ID: 7524758
[TBL] [Abstract][Full Text] [Related]
17. Structural requirements for function of the Crkl adapter protein in fibroblasts and hematopoietic cells.
Senechal K; Heaney C; Druker B; Sawyers CL
Mol Cell Biol; 1998 Sep; 18(9):5082-90. PubMed ID: 9710592
[TBL] [Abstract][Full Text] [Related]
18. Crkl is complexed with tyrosine-phosphorylated Cbl in Ph-positive leukemia.
de Jong R; ten Hoeve J; Heisterkamp N; Groffen J
J Biol Chem; 1995 Sep; 270(37):21468-71. PubMed ID: 7545163
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin and IL-3 induce tyrosine phosphorylation of CrkL and its association with Shc, SHP-2, and Cbl in hematopoietic cells.
Chin H; Saito T; Arai A; Yamamoto K; Kamiyama R; Miyasaka N; Miura O
Biochem Biophys Res Commun; 1997 Oct; 239(2):412-7. PubMed ID: 9344843
[TBL] [Abstract][Full Text] [Related]
20. Physiological signals and oncogenesis mediated through Crk family adapter proteins.
Feller SM; Posern G; Voss J; Kardinal C; Sakkab D; Zheng J; Knudsen BS
J Cell Physiol; 1998 Dec; 177(4):535-52. PubMed ID: 10092207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
